Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Immune Responses to RNA Viruses.

Said EA, Diaz-Griffero F, Bonte D, Lamarre D, Al-Jabri AA.

J Immunol Res. 2018 Jun 12;2018:5473678. doi: 10.1155/2018/5473678. eCollection 2018. No abstract available.

2.

Viruses Seen by Our Cells: The Role of Viral RNA Sensors.

Said EA, Tremblay N, Al-Balushi MS, Al-Jabri AA, Lamarre D.

J Immunol Res. 2018 Apr 30;2018:9480497. doi: 10.1155/2018/9480497. eCollection 2018. Review.

3.

Importin β1 targeting by hepatitis C virus NS3/4A protein restricts IRF3 and NF-κB signaling of IFNB1 antiviral response.

Gagné B, Tremblay N, Park AY, Baril M, Lamarre D.

Traffic. 2017 Jun;18(6):362-377. doi: 10.1111/tra.12480. Epub 2017 May 2.

4.

Correction: Spliceosome SNRNP200 Promotes Viral RNA Sensing and IRF3 Activation of Antiviral Response.

Tremblay N, Baril M, Chatel-Chaix L, Es-Saad S, Park AY, Koenekoop RK, Lamarre D.

PLoS Pathog. 2017 Jan 24;13(1):e1006174. doi: 10.1371/journal.ppat.1006174. eCollection 2017 Jan.

5.

Association of a Network of Interferon-Stimulated Genes with a Locus Encoding a Negative Regulator of Non-conventional IKK Kinases and IFNB1.

Jeidane S, Scott-Boyer MP, Tremblay N, Cardin S, Picard S, Baril M, Lamarre D, Deschepper CF.

Cell Rep. 2016 Oct 4;17(2):425-435. doi: 10.1016/j.celrep.2016.09.009.

6.

Spliceosome SNRNP200 Promotes Viral RNA Sensing and IRF3 Activation of Antiviral Response.

Tremblay N, Baril M, Chatel-Chaix L, Es-Saad S, Park AY, Koenekoop RK, Lamarre D.

PLoS Pathog. 2016 Jul 25;12(7):e1005772. doi: 10.1371/journal.ppat.1005772. eCollection 2016 Jul. Erratum in: PLoS Pathog. 2017 Jan 24;13(1):e1006174.

7.

Intact dendritic cell pathogen-recognition receptor functions associate with chronic hepatitis C treatment-induced viral clearance.

Rodrigue-Gervais IG, Rigsby H, Jouan L, Willems B, Lamarre D.

PLoS One. 2014 Jul 17;9(7):e102605. doi: 10.1371/journal.pone.0102605. eCollection 2014.

8.

A functional screen reveals an extensive layer of transcriptional and splicing control underlying RAS/MAPK signaling in Drosophila.

Ashton-Beaucage D, Udell CM, Gendron P, Sahmi M, Lefrançois M, Baril C, Guenier AS, Duchaine J, Lamarre D, Lemieux S, Therrien M.

PLoS Biol. 2014 Mar 18;12(3):e1001809. doi: 10.1371/journal.pbio.1001809. eCollection 2014 Mar.

9.

Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches.

Germain MA, Chatel-Chaix L, Gagné B, Bonneil É, Thibault P, Pradezynski F, de Chassey B, Meyniel-Schicklin L, Lotteau V, Baril M, Lamarre D.

Mol Cell Proteomics. 2014 Jan;13(1):184-203. doi: 10.1074/mcp.M113.030155. Epub 2013 Oct 29.

10.

A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle production.

Chatel-Chaix L, Germain MA, Motorina A, Bonneil É, Thibault P, Baril M, Lamarre D.

J Virol. 2013 Nov;87(21):11704-20. doi: 10.1128/JVI.01474-13. Epub 2013 Aug 28.

11.

Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses.

Baril M, Es-Saad S, Chatel-Chaix L, Fink K, Pham T, Raymond VA, Audette K, Guenier AS, Duchaine J, Servant M, Bilodeau M, Cohen E, Grandvaux N, Lamarre D.

PLoS Pathog. 2013;9(6):e1003416. doi: 10.1371/journal.ppat.1003416. Epub 2013 Jun 13.

12.

Tollip-induced down-regulation of MARCH1.

Bourgeois-Daigneault MC, Pezeshki AM, Galbas T, Houde M, Baril M, Früh K, Amrani A, Ishido S, Lamarre D, Thibodeau J.

Results Immunol. 2013 Feb 20;3:17-25. doi: 10.1016/j.rinim.2013.02.002. eCollection 2013.

13.

Staying ahead of viruses: a never ending task.

Lamarre D, Wainberg MA.

Curr Opin Virol. 2012 Oct;2(5):569-71. doi: 10.1016/j.coviro.2012.09.002. Epub 2012 Sep 29. No abstract available.

PMID:
23025913
14.

Regulators of innate immunity as novel targets for panviral therapeutics.

Es-Saad S, Tremblay N, Baril M, Lamarre D.

Curr Opin Virol. 2012 Oct;2(5):622-8. doi: 10.1016/j.coviro.2012.08.009. Epub 2012 Sep 25. Review.

PMID:
23017246
15.

Direct-acting and host-targeting HCV inhibitors: current and future directions.

Chatel-Chaix L, Germain MA, Götte M, Lamarre D.

Curr Opin Virol. 2012 Oct;2(5):588-98. doi: 10.1016/j.coviro.2012.08.002. Epub 2012 Sep 5. Review.

PMID:
22959589
16.

Effects of long exposure to low temperatures on nitrifying biofilm and biomass in wastewater treatment.

Delatolla R, Tufenkji N, Comeau Y, Gadbois A, Lamarre D, Berk D.

Water Environ Res. 2012 Apr;84(4):328-38.

PMID:
22834221
17.

Y-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle production.

Chatel-Chaix L, Melançon P, Racine MÈ, Baril M, Lamarre D.

J Virol. 2011 Nov;85(21):11022-37. doi: 10.1128/JVI.00719-11. Epub 2011 Aug 17.

18.

Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patients.

Jouan L, Chatel-Chaix L, Melançon P, Rodrigue-Gervais IG, Raymond VA, Selliah S, Bilodeau M, Grandvaux N, Lamarre D.

J Hepatol. 2012 Jan;56(1):70-7. doi: 10.1016/j.jhep.2011.07.017. Epub 2011 Aug 9.

PMID:
21835140
19.

[Hepatitis C virus subverts pattern recognition receptors-mediated control of adaptative immunity orchestrated by dendritic cells].

Rodrigue-Gervais IG, Lamarre D.

Med Sci (Paris). 2010 Oct;26(10):869-74. doi: 10.1051/medsci/20102610869. Review. French.

20.

Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the Tunnel.

Chatel-Chaix L, Baril M, Lamarre D.

Viruses. 2010 Aug;2(8):1752-65. doi: 10.3390/v2081752. Epub 2010 Aug 20.

Supplemental Content

Loading ...
Support Center